Anti-Liver Cancer Compound Library
Ref. TM-L2193
| 1mg | To inquire | |
| 30µl*10 (DMSO) | To inquire | |
| 50µl*10 (DMSO) | To inquire | |
| 100µl*10 (DMSO) | To inquire | |
| 250µl*10 (DMSO) | To inquire |
Product Information
1787 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies.
- The target pathways include PI3K/Akt/mTOR, EGFR, FGFR, Met, etc..
- Some compounds are already approved or in clinical phase.
- Detailed instructions, compound structures, target information, IC50 values, activity descriptions, etc.
- Various detection techniques such as NMR, HPLC/LCMS to ensure correct structure and high purity of the product and reduce false positives.
Chemical properties
Technical inquiry about: TM-L2193 Anti-Liver Cancer Compound Library
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
